NEFROPATÍA DIABÉTICA: Fisiopatología, Historia Natural, Diagnóstico Clínico y Manejo Terapéutico. Se anexa la presentación y resumen sobre el tema elaborado por el Postgrado de Medicina Interna del Hospital Universitario “Angel Larralde” de Valencia a cargo del Dr. Fernando Ayala.
- Diabetic kidney disease: a report from an ADA Consensus Conference. Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Diabetes Care. 2014 Oct;37(10):2864-83 PDF
- Updating the natural history of diabetic nephropathy. Pugliese G. Acta Diabetol. 2014 Dec;51(6):905-15. PDF
- Diabetes management in the kidney patient. Garg R, Williams ME. Med Clin North Am. 2013 Jan;97(1):135-56 PDF
- Early renal abnormalities as an indicator of cardiovascular risk in type 2 diabetes. Viazzi F, Bonino B, Ratto E, De Cosmo S, Pontremoli R. High Blood Press Cardiovasc Prev. 2014 Dec;21(4):257-60. PDF
- Biomarkers in diabetic nephropathy: Present and future. Currie G, McKay G, Delles C World J Diabetes. 2014 Dec 15;5(6):763-76. PDF
- Management of hyperglycemia in patients with chronic kidney disease. Aires Neto P Gomes HV Campos MJ Nephrol. 2013 Jul-Aug;26(4):629-35. doi: 10.5301/jn.5000248. Epub 2013 Jun 20.
- Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives. Lv M, Chen Z, Hu G, Li Q. Drug Discov Today. 2015 Mar;20(3):332-46.
- Metformin and other antidiabetic agents in renal failure patients. Lalau JD, Arnouts P, Sharif A, De Broe ME. Kidney Int. 2015 Feb;87(2):308-22.
- Pharmacokinetics and clinical use of incretin-based therapies in patients with chronic kidney disease and type 2 diabetes. Scheen AJ. Clin Pharmacokinet. 2015 Jan;54(1):1-21.
